Exhibit 107
Calculation of Filing Fee Tables
Form S-8
(Form Type)
iSpecimen Inc.
(Exact Name of Registrant as Specified in its Charter)
| Security Type | Security Class Title | Fee Calculation Rule | Amount Registered (1) | Proposed Maximum Aggregate Offering Price Per Share (2) | Maximum Aggregate Offering Price (2) | Fee Rate | Amount of Registration Fee | |||||||||||||||||||
| Equity | Common Stock, $0.0001 par value per share | Rules 457(c) and 457(h)(1) | 769,736 | $ | 1.365 | $ | 1,050,689 | 0.00015310 | $ | 160.86 | ||||||||||||||||
| Previously Paid | - | - | - | |||||||||||||||||||||||
| Total Offering Amounts | $ | 1,050,689 | 0.00015310 | $ | 160.86 | |||||||||||||||||||||
| Total Fees Previously Paid | - | |||||||||||||||||||||||||
| Total Fee Offsets | - | |||||||||||||||||||||||||
| Net Fee Due | $ | 160.86 | ||||||||||||||||||||||||
| (1) | This Registration Statement registers an additional 769,736 shares of common stock, $0.0001 par value per share (the “Common Stock”), of Dominari Holdings Inc. that will be reserved for issuance under the Dominari Holdings Inc. 2022 Equity Incentive Plan (f/k/a Akido Pharma Inc. 2022 Equity Incentive Plan. |
| (2) | Estimated solely for the purpose of calculating the registration fee which was computed in accordance with Rules 457(c) and 457(h)(1) under the Securities Act of 1933, as amended, on a basis of the average of the high and low sales prices of the Common Stock last reported on The Nasdaq Capital Market on December 19, 2024. |
